494 related articles for article (PubMed ID: 23725674)
1. Targeting protein-protein interactions as an anticancer strategy.
Ivanov AA; Khuri FR; Fu H
Trends Pharmacol Sci; 2013 Jul; 34(7):393-400. PubMed ID: 23725674
[TBL] [Abstract][Full Text] [Related]
2. The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.
Li Z; Ivanov AA; Su R; Gonzalez-Pecchi V; Qi Q; Liu S; Webber P; McMillan E; Rusnak L; Pham C; Chen X; Mo X; Revennaugh B; Zhou W; Marcus A; Harati S; Chen X; Johns MA; White MA; Moreno C; Cooper LA; Du Y; Khuri FR; Fu H
Nat Commun; 2017 Feb; 8():14356. PubMed ID: 28205554
[TBL] [Abstract][Full Text] [Related]
3. MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
Harati S; Cooper LA; Moran JD; Giuste FO; Du Y; Ivanov AA; Johns MA; Khuri FR; Fu H; Moreno CS
PLoS One; 2017; 12(1):e0170339. PubMed ID: 28118365
[TBL] [Abstract][Full Text] [Related]
4. Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View.
Dar KB; Bhat AH; Amin S; Anjum S; Reshi BA; Zargar MA; Masood A; Ganie SA
Curr Cancer Drug Targets; 2019; 19(6):430-448. PubMed ID: 30073927
[TBL] [Abstract][Full Text] [Related]
5. The OncoPPi Portal: an integrative resource to explore and prioritize protein-protein interactions for cancer target discovery.
Ivanov AA; Revennaugh B; Rusnak L; Gonzalez-Pecchi V; Mo X; Johns MA; Du Y; Cooper LAD; Moreno CS; Khuri FR; Fu H
Bioinformatics; 2018 Apr; 34(7):1183-1191. PubMed ID: 29186335
[TBL] [Abstract][Full Text] [Related]
6. Targeting Kinase Interaction Networks: A New Paradigm in PPI Based Design of Kinase Inhibitors.
Jenardhanan P; Panneerselvam M; Mathur PP
Curr Top Med Chem; 2019; 19(6):467-485. PubMed ID: 31184298
[TBL] [Abstract][Full Text] [Related]
7. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
Shin WH; Christoffer CW; Kihara D
Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Architecture of Deregulated Protein Complexes in Cancer.
Stefan E; Troppmair J; Bister K
Adv Protein Chem Struct Biol; 2018; 111():101-132. PubMed ID: 29459029
[TBL] [Abstract][Full Text] [Related]
9. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
[TBL] [Abstract][Full Text] [Related]
10. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
[TBL] [Abstract][Full Text] [Related]
11. The design and development of covalent protein-protein interaction inhibitors for cancer treatment.
Cheng SS; Yang GJ; Wang W; Leung CH; Ma DL
J Hematol Oncol; 2020 Mar; 13(1):26. PubMed ID: 32228680
[TBL] [Abstract][Full Text] [Related]
12. Discovering Innovative Drugs Targeting Both Cancer and Cardiovascular Disease by Shared Protein-Protein Interaction Network Analyses.
Tiwari S; Dwivedi UN
OMICS; 2019 Sep; 23(9):417-425. PubMed ID: 31329050
[TBL] [Abstract][Full Text] [Related]
13. Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?
Cierpicki T; Grembecka J
Immunol Rev; 2015 Jan; 263(1):279-301. PubMed ID: 25510283
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
Jimenez CR; Verheul HM
Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
[TBL] [Abstract][Full Text] [Related]
15. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
Ni D; Lu S; Zhang J
Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
[TBL] [Abstract][Full Text] [Related]
16. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
17. Computational Framework for Prediction of Peptide Sequences That May Mediate Multiple Protein Interactions in Cancer-Associated Hub Proteins.
Sarkar D; Patra P; Ghosh A; Saha S
PLoS One; 2016; 11(5):e0155911. PubMed ID: 27218803
[TBL] [Abstract][Full Text] [Related]
18. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
[TBL] [Abstract][Full Text] [Related]
19. The disruption of protein-protein interactions as a therapeutic strategy for prostate cancer.
Matos B; Howl J; Jerónimo C; Fardilha M
Pharmacol Res; 2020 Nov; 161():105145. PubMed ID: 32814172
[TBL] [Abstract][Full Text] [Related]
20. Protein-protein interactions: network analysis and applications in drug discovery.
Bultinck J; Lievens S; Tavernier J
Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]